Deane Retirement Strategies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-22,383
Closed -$2.2M 58
2020
Q2
$2.2M Sell
22,383
-255
-1% -$22.5K 1.6% 13
2020
Q1
$1.73M Buy
22,638
+213
+0.9% +$18.1K 1.28% 14
2019
Q4
$1.99M Sell
22,425
-9,452
-30% -$785K 1.36% 14
2019
Q3
$2.41M Buy
+31,877
New +$2.19M 1.72% 16
2018
Q1
Sell
-22,553
Closed -$2.48M 61
2017
Q4
$2.18M Sell
22,553
-499
-2% -$47K 2.03% 13
2017
Q3
$2.05M Sell
23,052
-854
-4% -$65K 1.98% 11
2017
Q2
$1.73M Buy
+23,906
New +$1.61M 1.39% 20

Other funds holding ABBV

Deane Retirement Strategies's ABBV Position: Q3 2020 in Review

Deane Retirement Strategies sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 22,383 shares — an estimated $2.2M sold.

Deane Retirement Strategies first reported a position in ABBV in Q2 2017 and held it in 7 quarters. The position peaked at $2.41M in Q3 2019. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Deane Retirement Strategies reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Deane Retirement Strategies sold 22,383 AbbVie shares in Q3 2020, an estimated $2.2M.
  • Deane Retirement Strategies first reported a position in AbbVie in Q2 2017 and held it in 7 quarters.
  • Deane Retirement Strategies's AbbVie position peaked at $2.41M in Q3 2019.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Deane Retirement Strategies's 13F filing for Q3 2020, filed 7 Oct 2020.